Article info

Download PDFPDF
10 Certolizumab pegol inhibits tumour necrosis factor-induced endothelial cell activation

Authors

  • S K Heathfield Arthritis Research UK Epidemiology Unit, School of Translational Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UKCardiovascular Research Group, School of Biomedicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • I Bruce Arthritis Research UK Epidemiology Unit, School of Translational Medicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • M Y Alexander Cardiovascular Research Group, School of Biomedicine, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles

Citation

Heathfield SK, Bruce I, Alexander MY
10 Certolizumab pegol inhibits tumour necrosis factor-induced endothelial cell activation

Publication history

  • First published September 23, 2011.
Online issue publication 
September 23, 2011

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.